AFTPF (AFT Pharmaceuticals) Price-to-Operating-Cash-Flow : 0.00 (As of Sep. 24, 2024)

View and export this data going back to 2022. Start your Free Trial

What is AFT Pharmaceuticals Price-to-Operating-Cash-Flow?

As of today (2024-09-24), AFT Pharmaceuticals's share price is $0.00. AFT Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.17. Hence, AFT Pharmaceuticals's Price-to-Operating-Cash-Flow Ratio for today is 0.00.

The historical rank and industry rank for AFT Pharmaceuticals's Price-to-Operating-Cash-Flow or its related term are showing as below:

AFTPF' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 10.18 Med: 31.93 Max: 701.43
Current: 11.53

During the past 9 years, AFT Pharmaceuticals's highest Price-to-Operating-Cash-Flow Ratio was 701.43. The lowest was 10.18. And the median was 31.93.

AFTPF's Price-to-Operating-Cash-Flow is ranked better than
66.57% of 676 companies
in the Drug Manufacturers industry
Industry Median: 16.635 vs AFTPF: 11.53

AFT Pharmaceuticals's Cash Flow from Operations per share for the six months ended in Mar. 2024 was $0.12. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.17.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of AFT Pharmaceuticals was 147.70% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 239.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 67.70% per year.

During the past 9 years, AFT Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 239.90% per year. The lowest was -10.10% per year. And the median was 130.70% per year.

AFT Pharmaceuticals Price-to-Operating-Cash-Flow Historical Data

The historical data trend for AFT Pharmaceuticals's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AFT Pharmaceuticals Price-to-Operating-Cash-Flow Chart

AFT Pharmaceuticals Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

23.53

707.14

26.74

31.17

11.38

AFT Pharmaceuticals Semi-Annual Data
	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial												26.74	-	31.17	-	11.38

Competitive Comparison of AFT Pharmaceuticals's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, AFT Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AFT Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AFT Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where AFT Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.

AFT Pharmaceuticals Price-to-Operating-Cash-Flow Calculation

AFT Pharmaceuticals's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.00	/	0.166
	=	0.00

AFT Pharmaceuticals's Share Price of today is $0.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. AFT Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.17.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

AFT Pharmaceuticals Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of AFT Pharmaceuticals's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

AFT Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AFT Pharmaceuticals Ltd (OTCPK:AFTPF) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

AFT:New Zealand AFP:Australia

Address

129 Hurstmere Road, Level 1, Takapuna, Auckland, NTL, NZL, 0622

Website

https://www.aftpharm.com

AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Aqueous cream, Calci-tab, Maxigesic, Cromo-fresh, Crystaderm, Crytawash, Ellgy plus, Emulsifying ointment, and others. The group has four operating segments based on geographical location being, Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia which includes the sales and distribution activity relating to the Australian market.